“Comprehensive Analysis of Factors Influencing Recurrence and Survival in Glioblastoma: Implications for Treatment Strategies”: A Single Center Study
Glioblastoma is a highly aggressive malignancy affecting the brain and central nervous system. It is the most common malignant primary brain tumor, yet its prognosis remains poor. Median survival typically ranges from around 13 months with standard treatment to up to 19.9 months in some recent clini...
Saved in:
| Main Authors: | Ahmed Bendari, Sunder Sham, Hamed Hammoud, Oana Vele, Brett Baskovich, David Huang, Alaa Bendari, Rachel Saks, Reham Al-Refai, Tasneem Bendari, Layth Kataw, Fnu Kiran, Fnu Anjali, Sanjay Kirshan Kumar, Manju Harshan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Journal of Molecular Pathology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-5261/5/4/35 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A high number of tumor deposits (≥ 4) is an isolated predictor of local recurrence and distant metastasis in non-metastatic colorectal cancer: a single center study
by: Ahmed Bendari, et al.
Published: (2025-01-01) -
Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated
by: Malcolm F. McDonald, et al.
Published: (2025-01-01) -
Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
by: Anne Clavreul, et al.
Published: (2024-11-01) -
High p16INK4A expression in glioblastoma is associated with senescence phenotype and better prognosis
by: Soon Sang Park, et al.
Published: (2025-02-01) -
The prognostic value and biological significance of MRI CE-T1-based radiomics models in CNS5-identified GBM: a multi-center study
by: Mingwei Zhang, et al.
Published: (2024-11-01)